Human GM-CSF Platinum ELISA

Description: The human GM-CSF ELISA is an enzyme-linked immunosorbent assay for the quantitative detection of human GM-CSF. The human GM-CSF ELISA is for research use only. Not for diagnostic or therapeutic procedures.

Granulocyte - macrophage colony - stimulating factor (GM-CSF) is a small glycoprotein growth factor which stimulates the production and function of neutrophils, eosinophils and monocytes GM-CSF can be produced by a wide variety of tissue types, including fibroblasts, endothelial cells, T-cells, macrophages, mesothelial cells, epithelial cells and many types of tumor cells. In most of these tissues, inflammatory mediators, such as interleukin-1, interleukin-6, tumor necrosis factor or endotoxin, are inducers of GM-CSF gene expression, which occurs at least partly by post-transcriptional modification of the GM-CSF mRNA.
The biological effects of GM-CSF are mediated through binding to cell surface receptors, which appear to be widely expressed by hematopoietic cells and also by some non-hematopoietic cells, such as endothelial cells. At least two different functional classes of GM-CSF receptor have been identified. The neutrophil GM-CSF receptor exclusively binds GM-CSF, while interleukin-3 competes for binding of GM-CSF to a second class of receptors detected on some leukemic cell lines. Monitoring of GM-CSF has been found relevant in human prostate cancer, poorly healing wounds, thyroid carcinoma, severe mucositis, fungal infections, AIDS, bone marrow transplantation, renal cell carcinoma and prostate cancer, acute lymphoblastic leukemia pulmonary inflammation, hematological malignancies, infection, lung cancer.

Citations: Boucharaba,Ahmed; Serre,Claire Marie; Guglielmi,Julien; Bordet,Jean Claude; Clezardin,Philippe; Peyruchaud,Olivier. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. Proceedings of the National Academy of Sciences U.S.A. 2006;103:9643-9648. (Link)

References: Bolwell,B.J.. The use of G-CSF and GM-CSF in bone marrow transplantation. Cleve.Clin.J.Med. 1993;60:291-302. (Link)

Groves,R.W.; Schmidt-Lucke,J.A.. Recombinant human GM-CSF in the treatment of poorly healing wounds. Adv.Skin Wound.Care 2000;13:107-112. (Link)

Toren,A.; Nagler,A.. The implications of granulocyte-monocyte colony-stimulating factor (GM-CSF) in cytotoxicity of bone marrow transplantation. Cytokines Cell Mol.Ther. 1998;4:199-206. (Link)

Burgess,A.W.; Metcalf,D.. The nature and action of granulocyte-macrophage colony stimulating factors. Blood 1980;56:947-958. (Link)

Ross,S.D.; DiGeorge,A.; Connelly,J.E.; Whiting,G.W.; McDonnell,N.. Safety of GM-CSF in patients with AIDS: a review of the literature. Pharmacotherapy 1998;18:1290-1297. (Link)

Lim,M.; Simons,J.W.. Emerging concepts in GM-CSF gene-transduced tumor vaccines for human prostate cancer. Curr.Opin.Mol Ther. 1999;1:64-71. (Link)

Drings,P.; Fischer,J.R.. Biology and clinical use of GM-CSF in lung cancer. Lung 1990;168 Suppl:1059-1068. (Link)

Freund,M.; Kleine,H.D.. The role of GM-CSF in infection. Infection 1992;20 Suppl 2:S84-S92. (Link)

Lowenberg,B.; de Greef,G.E.; Wielenga,J.J.. Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignancies. Anticancer Drugs 1993;4 Suppl 1:17-20. (Link)

Jones,T.C.. Use of granulocyte-macrophage colony stimulating factor (GM-CSF) in prevention and treatment of fungal infections. Eur.J.Cancer 1999;35 Suppl 3:S8-10. (Link)

Griffin,J.D.; Cannistra,S.A.; Sullivan,R.; Demetri,G.D.; Ernst,T.J.; Kanakura,Y.. The biology of GM-CSF: regulation of production and interaction with its receptor. Int.J.Cell Cloning 1990;8 Suppl 1:35-44. (Link)

Harmenberg,J.; Hoglund,M.; Hellstrom-Lindberg,E.. G- and GM-CSF in oncology and oncological haematology. Eur.J.Haematol.Suppl 1994;55:1-28. (Link)

Hejna,M.; Brodowicz,T.; Zielinski,C.C.. Local use of GM-CSF for severe mucositis. Eur.J.Cancer 1999;35 Suppl 3:S14-S17. (Link)

Harousseau,J.L.; Wu,D.. The use of GM-CSF and G-CSF in the treatment of acute leukemias. Leuk.Lymphoma 1995;18:405-412. (Link)

Hoshi,S.; Yoshizawa,A.; Arioka,H.; Kobayashi,N.; Kudo,K.; Niino,H.. [Anaplastic thyroid carcinoma with lung metastasis producing CA 19-9 and GM-CSF]. Nihon Kokyuki.Gakkai Zasshi 2000;38:391-397. (Link)